Orexigen: Anti-Obesity Drug Attempting to Enter Multiple Markets

Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.

Read more »

OneMedPlace announces program for the Seventh Annual OneMedForum: Investing in Healthcare 2014, Jan. 13-15

OneMedPlace announces program for the Seventh Annual OneMedForum: Investing in Healthcare 2014, Jan. 13-15

Read more »

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean […]

Read more »

Test Post

Read more »

“The Value Proposition of the JOBS Act and Reg A” How Will Capital Market Structures Assess Valuation for Smaller Medical Technology Companies After the JOBS Act?

There has been much debate of how the capital market landscape is looking to shape up for bioscience companies with […]

Read more »

PDUFA: Flamel Technologies S.A. — Undisclosed Product, May 31, 2013

Read more »

Editor’s Note: May 2, 2013

Hard to believe we are just a few weeks away from OneMedForumNY 2013, June 26-27 in New York City. We’re […]

Read more »

Editor’s Note: April 16, 2013

Much excitement surrounding the industry this month. The recent Adult Stem Cell Conference at the Vatican has once again sparked […]

Read more »

OneMedPlac

Read more »

Read more »